BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 868752)

  • 1. OSHA announces proposed cancer policy..
    Am Ind Hyg Assoc J; 1977 Apr; 38(4):A24-9. PubMed ID: 868752
    [No Abstract]   [Full Text] [Related]  

  • 2. Measures for the prevention of occupational cancer.
    Weaver NK
    J Occup Med; 1976 Sep; 18(9):607-10. PubMed ID: 966092
    [No Abstract]   [Full Text] [Related]  

  • 3. Why the delay in cancer-protection standards?
    Rose V
    Occup Health Saf; 1977; 46(3):49-50. PubMed ID: 194192
    [No Abstract]   [Full Text] [Related]  

  • 4. AOMA criticizes OSHA carcinogen proposal.
    Occup Health Saf; 1978; 47(5):13. PubMed ID: 692966
    [No Abstract]   [Full Text] [Related]  

  • 5. The approach used by the Occupational Safety and Health Administration (OSHA) to regulate occupational carcinogens.
    Rowland R
    Med Lav; 1986; 77(4):457-66. PubMed ID: 3784958
    [No Abstract]   [Full Text] [Related]  

  • 6. AHA protests OSHA action on nitrous oxide level.
    Hospitals; 1979 Oct; 53(20):19. PubMed ID: 478463
    [No Abstract]   [Full Text] [Related]  

  • 7. Noise is a prime target at OSHA.
    Corn M
    Occup Health Saf; 1976; 45(4):12-7. PubMed ID: 181704
    [No Abstract]   [Full Text] [Related]  

  • 8. Occupational health's future.
    Baier EJ
    J Occup Med; 1975 Mar; 17(3):171-2. PubMed ID: 1123686
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulators and workplace carcinogens.
    Yodaiken RE; Jones E; Spolnicki HG; Deitchman S
    Occup Med; 1987; 2(1):197-206. PubMed ID: 3306975
    [No Abstract]   [Full Text] [Related]  

  • 10. The renewed dialogue between science and labor.
    Clayman J
    Prev Med; 1972 Aug; 1(3):382-7. PubMed ID: 5085005
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of carcinogenicity classifications and evaluations: the case of formaldehyde.
    Binetti R; Costamagna FM; Marcello I
    Ann Ist Super Sanita; 2006; 42(2):132-43. PubMed ID: 17033133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiencies of science and policy in generic cancer regulation by the Occupational Safety and Health Administration.
    Hoerger FD; Conder JW
    Ann N Y Acad Sci; 1981; 363():21-7. PubMed ID: 6942723
    [No Abstract]   [Full Text] [Related]  

  • 13. Agencies in dispute over cancer policy.
    Sun M
    Science; 1982 Jul; 217(4556):233. PubMed ID: 7089559
    [No Abstract]   [Full Text] [Related]  

  • 14. How do you inform labor, management, and other professionals about toxicity data?
    Sprout WL
    Occup Health Saf; 1978; 47(2):20-1. PubMed ID: 634522
    [No Abstract]   [Full Text] [Related]  

  • 15. The International Agency for Research on Cancer experience in the evaluation of the carcinogenic risk to humans.
    Simonato L; Tomatis L
    Med Lav; 1986; 77(4):323-9. PubMed ID: 3784938
    [No Abstract]   [Full Text] [Related]  

  • 16. I. Recommendations for a benzene standard.
    J Occup Med; 1976 Jul; 18(7):499-504. PubMed ID: 940004
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical agents and occupational cancer.
    Cole P; Merletti F
    J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):399-417. PubMed ID: 6993616
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical surveillance and biomonitoring for occupational cancer endpoints.
    Cone JE; Rosenberg J
    Occup Med; 1990; 5(3):563-81. PubMed ID: 2218803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive occupational carcinogen policy as a framework for regulatory activity.
    Ruttenberg R; Bingham E
    Ann N Y Acad Sci; 1981; 363():13-20. PubMed ID: 6942718
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinogens at work: scientific and regulatory aspects. Proceedings of the international conference. Roma, 13-14 June, 1985.
    Med Lav; 1986; 77(4):323-479. PubMed ID: 3784937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.